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Manganese superoxide dismutase (Mn-SOD), localized at the mitochondrial matrix, has the ability to protect cells against oxidative
damage. It has been reported that low levels of Mn-SOD gene expression cause the development of certain kind of tumors. On the
other hand, overexpression of Mn-SOD gene may play an important role in the development of cancer. In our study, we ﬁnd that
Mn-SOD activity was higher in nonaggressive (MCF-7) and aggressive (BT-549 and 11-9-14) breast cancer cell lines compared to that
of nontumorigenic (MCF-12A and MCF-12F) mammary epithelial cell lines. We also observed an increased expression of Mn-SOD
geneincancerouscelllines.TheelevatedlevelofSODactivityinnonaggressiveandaggressivebreastepithelialcelllineswasassociated
with some changes in nucleotide sequence.
INTRODUCTION
Carcinoma of the breast, the third most common can-
cer worldwide, accounts for the highest morbidity and
mortality [1]. It is also the second leading cause of can-
cer death in women, after lung cancer [2]. The etiology
of breast cancer is multifactorial. Hormonal, genetic, and
environmental factors are implicated in the pathogenesis
of breast cancer [3]. Furthermore, reactive oxygen species
(ROS),suchassuperoxideanionsandhydrogenperoxide-
inducedlipidperoxidation,playamajorroleinmalignant
transformation [4] and tumor cell proliferation and inva-
sion[5,6,7].Ithasbeenhypothesizedthattheproduction
of ROS in combination with a decrease in the activity of
antioxidant enzymes may be characteristic of tumor cells
[8, 9].
Superoxide dismutase (SOD) is a family of ubiq-
uitous antioxidant metalloproteinases that catalyze the
conversion of superoxide anion radicals to hydrogen per-
oxide and molecular oxygen [10]. Three diﬀerent iso-
formsofSOD(cytosolicCu/ZnSODorSOD1,mitochon-
drial Mn-SOD or SOD2, and extracellular SOD or SOD3)
exist within this family. Among these three, manganese
superoxide dismutase (Mn-SOD) which is localized at the
mitochondrial matrix [11, 12, 13] has shown the ability
to reverse malignant phenotype in a variety of human tu-
mor cells that are low or absent in Mn-SOD expression. It
has been hypothesized that the Mn-SOD gene is a tumor
suppressor [14, 15]. Mn-SOD activity has been reported
to be decreased in many transformed cell lines suggest-
ing that an altered Mn-SOD gene may play an important
role in the development of cancer [16, 17, 18, 19]. The
purpose of the present study was to investigate whether
ad i ﬀerential expression of Mn-SOD exists between non-
tumorigenic human mammary epithelial cell lines (MCF-
12A and MCF-12F), nonaggressive human breast cancer
celllines(MCF-7)andaggressivecanceroushumanmam-
mary epithelial cell lines (BT-549 and 11-9-14).
MATERIALS AND METHODS
Maintenanceofhumanmammaryepithelialcelllines
Five cell lines representing nontumorigenic (MCF-
12A and MCF-12F), nonaggressive cancerous (MCF-7),
and aggressive cancerous (11-9-14 and BT-549) human
mammary epithelial cells were used in this study. All
cell lines except 11-9-14 were obtained from ATCC, Va.
11-9-14 cell line was obtained from the Tissue Pro-
curement Facility, Meharry Medical College, Nashville,
Tenn. It was originated from the human breast ep-
ithelial cell line BT-549 at ATCC and transfected with
galectin-3, a β-galactoside binding protein (a cell adhe-
sion molecule). The cells were cultured in DMEM/F-12,
supplemented with 100µg/mL penicillin-streptomycin,
2.5µg/mL fungizone, 20ng/mL epidermal growth factor,
98ng/mLcholeratoxin,10%heat-inactivatedfetalbovine
serum, 2mM glutamine, and nonessential amino acids.196 Sutapa Mukhopadhyay et al 2004:4 (2004)
The cultures were maintained at 37◦C in a humidiﬁed at-
mosphereof5%CO2 and95%air.Allcellculturesupplies
were purchased from Sigma, Mo.
AssayofSODactivity
SOD activity was measured using alkaline dimethyl
sulfoxide as superoxide anion generating system as fol-
lows. Samples to be assayed (200µL) were added to 1mL
of 0.20M potassium phosphate buﬀer (pH 8.6) contain-
ing 10−4 M EDTA and 2 × 10−5 Mc y t o c h r o m eC .T u b e s
were kept in an ice bath for 20minutes. Then, 0.5mLal-
kaline DMSO (DMSO containing 1% water and 5mM
NaOH) was added with stirring. After the addition of al-
kaline DMSO, the ﬁnal pH of the solution was usually be-
tween 9.5a n d9 .6. Absorbance of reduced cytochrome C
was determined at 550nm against samples prepared un-
der similar conditions except that DMSO did not contain
NaOH.Mn-SODactivitywasdeterminedafterincubating
the cell lysates with 50mM NaCN because NaCN inhibits
the activity of cytosolic Cu-Zn SOD. The ﬁnal concentra-
tion of NaCN in the assay mixture was 5mM. A unit of
enzymatic activity is the amount of enzyme, which causes
50% inhibition of alkaline DMSO-mediated cytochrome
cr e d u c t i o n[ 20].
IsolationofRNA
RNA was isolated from 106 cells using Trizol (Invitro-
gen, Md). Cells were ﬁrst washed with sterile PBS three
times and resuspended in 1mL Trizol and sonicated in a
Branson soniﬁer cell disrupter. The mixture was kept in
roomtemperaturefor5minutes.Then200µLchloroform
was added and the mixture was vigorously shaken. The
phases were separated by centrifuging at 12000rpm for
15minutes at 4◦C. The RNA was then precipitated from
the aqueous phase with isopropanol (25◦C). The pellet
was washed with ample amounts of sterile, 70% ethanol
(25◦C). The concentration and the purity of the RNA
were analyzed in a UV spectrophotometer.
Slotblothybridization
Slot blot hybridization was performed using increas-
ingamountsofRNAfromallsamples.Thereverseprimer,
5 GTATCTTTCAGTTACATTCTCCCA-3 ,f o rS O Da n d
forward primer, 5 GTGGAGTCTACTGGCGTCTTC-3 ,
for GAPDH were digoxigenin-labeled for slot blot hy-
bridization using the Terminal DIG labeling kit (Roche
Biochemicals, Ind). Diﬀerent amounts of RNA (0, 1, 2,
and 4µg) from all cells were loaded onto a positively
charged nylon membrane (MSI, Ga) using a Turboblot-
ter (BioRad, Calif). The samples were then linked to the
membrane using a UV crosslinker (Stratagene, Calif).
A nonradioactive detection method using digoxigenin
(Roche Biochemicals, Ind) was used to detect any hy-
bridization. The membranes were washed under high-
stringent conditions with 0.1 × SSC and 0.1% SDS at
600◦C for 1 hour before being exposed to the ﬁlm. The
labeled reverse primer was used as the probe and the hy-
bridization was performed following manufacturer’s in-
structions. The band intensities (IDV values) were quan-
titated using the alpha imager (Alpha Innotech, Calif).
Reversetranscriptase-polymerasechainreaction
RT-PCR of both SOD and GAPDH was per-
formed using 5µg RNA from each sample, using the
One-Step RT-PCR kit (Invitrogen, Md). The primers
were synthesized to amplify approximately 200 amino
acids in the carboxyl end of the protein and based
on the sequences from the GenBank Accession No.
M36693. The primer sequences were 5 -TTGAGCCGGG
CAGTGTGCGGCACC-3  (forward) and 5 -GTATCTT
TCAGTTACATTCTCCCA-3  (reverse) for SOD, and
5 GTGGAGTCTACTGGCGTCTTC-3  (forward) and
5  CATGCCAGTGAGCTTCCCGTT-3  (reverse) for
GAPDH. RT-PCR was performed in a thermal cycler
(Biometra, Tgradient) as follows: 1 cycle for 30minutes
at 45◦C, 1 cycle for 2minutes at 94◦C, 39 cycles for
1minute at 94 ◦C, 1minute at 50◦C, 2minutes at 72◦C
and 1 cycle for 10minutes at 72◦C. The RT-PCR products
were electrophoresed on a 1% agarose gel, puriﬁed
using QIAquick PCR puriﬁcation kit (Qiagen, Calif),
and sequenced using BigDye terminators kit (Applied
Biosystems, Calif). The sequences were analyzed using
Applied Biosystems automated sequencer (ABI 3700
model).
Statisticalanalysis
Diﬀerences between tumorigenic and nontumori-
genic cells were assessed by using ANOVA, and the sig-
niﬁcance level was set at P ≤ .05.
RESULTS
ActivityofSOD
T o t a la sw e l la sM n - S O Da c t i v i t yw a sv a r i e db e -
tween cell lines (Table 1). The order of activity was MCF-
7 (nonaggressive) > BT-549 and 11-9-14 (aggressive) >
MCF-12A and MCF-12F (nontumorigenic).
ExpressionofMn-SODgene
An RT-PCR yielded products of approximately 0.6kb
for SOD and 0.4kb for GAPDH in all cell lines. The re-
sults showed the diﬀerential expression of Mn-SOD gene
between nontumorigenic, nonaggressive, and aggressive
breast cancer cell lines (BT-549 and 11-9-14) (Figure 1).
A slot blot hybridization (Figure 2) was done with in-
creasing amounts of RNA from nontumorigenic (MCF-
12A and MCF-12F), nonaggressive cancerous (MCF-7),
and aggressive cancerous (BT-549 and 11-9-14) cell lines
to conﬁrm their diﬀerential expression of Mn-SOD RNA.
The housekeeping gene, GAPDH, was used as a positive
control. No change in the expression of GAPDH was ob-
served with increasing concentration of RNA. The quan-
titative analysis of the RNA levels shown in Figure 2 has
been normalized with the RNA level of GAPDH gene2004:4 (2004) Diﬀerential Expression of Mn-SOD Gene 197
Table 1. Activity of SOD in diﬀerent cell lines (values are mean ± SEM, n = 5). ∗Values in cancer cell lines (MCF-7, BT-549, 11-9-14)
are signiﬁcantly diﬀerent from those in normal cell lines (MCF-12A and MCF-12F), P<. 05.
Cell line Total SOD activity (unit/mg protein) Mn-SOD activity (unit/mg protein)
MCF-12A 17.77 ±1.563 3.04 ±0.35
MCF-12F 21.72 ±1.508 2.42 ±0.12
MCF-7 42.76 ±5.717∗ 16.38 ±1.13∗
BT-549 28.47 ±1.215∗ 7.83 ±0.47∗
11-9-14 29.49 ±0.858∗ 10.69 ±0.29∗
GAPDH (0.4kb)
SOD (0.6kb)
123456
Figure 1. Reverse transcriptase-polymerase chain reaction. The
gel picture showing diﬀerential RT-PCR product. Lane 1 : 5 µg
RNA from MCF-12A in RT-PCR; lane 2 : 5 µgR N Af r o mM C F -
12F in RT-PCR; lane 3 : 5 µg RNA from MCF-7 in RT-PCR; lane
4:5µg RNA from BT-549 in RT-PCR; lane 5 : 5 µgR N Af r o m
11-9-14 in RT-PCR; lane 6 : 1 kb plus marker.
(Table 2) which indicates that the band intensities are dif-
ferent between these cell lines. Highest expression was ob-
served in MCF-7 in comparison with others. Expression
was lowest in MCF-12A.
SequencingofRT-PCRproductsofMn-SODgene
The RT-PCR products from MCF-12A, MCF-12F,
MCF-7, BT-549, and 11-9-14 were sequenced and each
nucleotide sequence was compared with that of the hu-
m a nM n - S O Dg e n ea sr e p o r t e di nN C B Id a t ab a s e
(M36693). We have shown here the alignment of the nu-
cleotide sequence of one representative human breast cell
line (MCF-12A) with that of the human Mn-SOD from
GenBank (Accession No. M36693) (Figure 3).
With our primers, we could sequence 627 to 652
nucleotides depending on the cell lines (Table 3). This
sequence exactly aligns to a segment (98–746) of the hu-
man Mn-SOD cDNA (976bp, GenBank Accession No.
M36693). In MCF-12A and MCF-12F, we found three
basechangesinthenucleotidelevel(Table 4).Oneofthese
was common in both (c339t). The two other changes were
diﬀerent between MCF-12A (g130c and c139t)a n dM C F -
12F(c141t and t625c).WhenthesequencesofMCF-7,BT-
549, and 11-9-14 were compared with that of M36693,
we found only one substitution in each of these cell lines
(Table 3). In both MCF-7 and 11-9-14 cell lines, this
change was from c to t (c339t)a so b s e r v e di nb o t hM C F -
12A and MCF-12F. However, in BT-549, it was from c to t
at 141 (c141t).
The nucleotide sequence was translated using hu-
man codon usage to give a peptide sequence of 209–217
amino acids (Table 4). This sequence exactly corresponds
to a segment (2–217) of the Mn-SOD peptide sequence
of M36693 (GenBank). For MCF-12A, three amino acid
c h a n g e sw e r ef o u n d( Q12H, A16V, T82I). Two changes
were observed for MCF-12F cell line (A16V, T82I). But in
other cell lines, only one amino acid substitution (T82I
in MCF-7 and 11-9-14, and A16V in BT-549) was found.
The alignment of the peptide sequence of one represen-
tative human breast cell line (MCF-12A) with that of the
human Mn-SOD from the GenBank (M36693) is shown
in Figure 4.
DISCUSSION
Mn-SOD plays a key role in protecting cells against
oxidative damage and regulating cellular concentration of
O
·
2, which is a highly reactive oxidant and an unwanted
product of cellular metabolism [21]. Many diﬀerent types
of tumors have been demonstrated to have low Mn-SOD
activity [22]. Overexpression of Mn-SOD suppresses the
tumorigenicity of human melanoma cells, breast cancer
cells,andgliomacells,suggestingthatMn-SODisatumor
suppressor gene in a wide variety of cancers [15, 23, 24].
Several reports have however shown that despite gen-
erally low levels of Mn-SOD in the center of solid tumor
nests, there appeared to be very intense Mn-SOD stain-
ing in a few tumor cells located at the leading edge or
outside layers of tumors adjacent to benign epithelium in
breastandprostatetumors[25,26].Inaddition,Mn-SOD
expression is increased in metastatic gastric cancer [27].
Lam et al [28] demonstrated that overexpression of Mn-
S O Db ya d e n o v i r u sg e n et r a n s f e ri nh a m s t e rs q u a m o u s
carcinoma cells stimulated tumor cell invasive capac-
ity and this elevation was abolished by adenovirus cata-
lase suggesting the involvement of ROS and particularly
by hydrogen peroxide in the process of tumor invasion.198 Sutapa Mukhopadhyay et al 2004:4 (2004)
MCF-12A
01 2 4
MCF-12F
01 2 4
MCF-7
GAPDH
SOD
01 2 4
BT-549
MCF-12A
11-9-14
GAPDH
SOD
Figure 2. Slot blot hybridization. Increasing amounts of RNA (0, 1, 2, and 4µg) were taken from MCF-12A, MCF-12F, MCF-7,
BT-549, and 11-9-14 breast epithelial cells and hybridized with probe.
Reconstitution of Mn-SOD in tumor cells induces cell re-
sistance to the cytotoxic eﬀects of TNF-α, ionizing, and
hyperthermia [29, 30, 31], suggesting that Mn-SOD func-
tions not only as a tumor suppressor but also as a media-
tor in signaling cell resistance to ROS-induced cytotoxic-
ity [32].
In our study, we ﬁnd high activity of Mn-SOD in cer-
tain breast cancer cell lines especially in MCF-7 cell line
(Table 1). We speculate that this elevation of Mn-SOD in
cancerous breast tissues without a corresponding increase
in the activity of catalase and/or glutathione peroxidase
would lead to the accumulation of peroxides and oxida-
tive stress and will enhance the progression of cancer.
Siemankowski et al [31] also showed a similar kind of ac-
tivity (∼ 40U SOD/mg protein) in MCF-7 cell line. Mn-
S O Dm a yp l a yad u a lr o l ei nr e l a t i o nt oe x p o s u r et oR O S .
Human cancer has frequently decreased Mn-SOD levels.
However, although it is clearly an important scavenger of
ROS, the production of H2O2 by Mn-SOD in speciﬁc cir-
cumstances may lead to potentially carcinogenic eﬀects,
especially if some individuals have a decreased capacity to
remove H2O2 by glutathione peroxidase or catalase. Al-
ternatively, better scavenging capacity may decrease the
ability to undergo normal cellular protective mechanisms
such as apoptosis; therefore, oxidative stresses would have
a greater likelihood of nuclear DNA mutation [33, 34].
According to our results (Tables 3 and 4) ,aG -t oC -s u b -
stitution in 130 positions in MCF-12A (nontumorigenic)
was found that changes the amino acid codon at 12 po-
sitions in the peptide from Q to H. But this change was
not observed in MCF-7, BT-549, and 11-9-14 cell lines.
Rosenblum et al [35]suggestthatthealterationmayaﬀect
thecellularallocationoftheenzymeandtransportofMn-
SOD into the mitochondrion where it would be biologi-
callyavailable.Theyfurthersuggestthatineﬃcient target-
ing of Mn-SOD could leave mitochondria without their
full defense against superoxide radicals, which could lead
to protein oxidation as well as mitochondrial DNA mu-
tations. Overexpression of Mn-SOD perhaps causes (a) a
decrease in the malignant phenotypes of various types of
cancer including breast cancer [15, 23], (b) an increase in
the resistance for cytotoxicity from tumor necrosis factor
α in breast cancer [30, 36], (c) an increase in apoptosis
[37], and (d) an improvement in apoptosis after hydro-
gen peroxide challenge [37]. It is also possible that mito-
chondrial Mn-SOD could impact on oxidative damage in
nuclear DNA, which would be one plausible mechanism
for increased risk from a genetic polymorphism in Mn-
SOD, although the eﬀects on the mitochondrion alone
could be suﬃcient for its impact on carcinogenesis. Thus,
there are a number of ways that changes in the cellular
distribution of Mn-SOD might aﬀect breast cancer risk.2004:4 (2004) Diﬀerential Expression of Mn-SOD Gene 199
Table 2. Band intensities (IDV values) of slot blot for normal and cancer cell lines at diﬀerent RNA concentrations. (Values are mean
± SEM, n = 5). Values in cancer cell lines (MCF-7, BT-549, and 11-9-14) are signiﬁcantly diﬀerent from those in normal cell lines
(MCF-12A and MCF-12F), P<. 05.
RNA conc.
(µg)
IDV values
MCF-12A MCF-12F MCF-7 BT-549 11-9-14
0 0 0 000
1 0.95 ±0.003 1.53 ±0.03 4.49 ±0.002 1.97 ±0.002 1.91 ±0.001
2 1.37 ±0.05 2.11 ±0.04 4.71 ±0.12 .84 ±0.06 3.25 ±0.04
4 1.76 ±0.08 2.44 ±0.14 5.37 ±0.49 3.24 ±0.11 3.04 ±0.61
MCF-12A 1 ttgagccgggcagtgtgcggcaccagcaggcagctggctccggttttggggtatctgggc
||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||
M36693 98 ttgagccgggcagtgtgcggcaccagcaggcagctggctccggctttggggtatctgggc
MCF-12A 61 tccaggcagaagcacagcctccccgacctgccctacgactacggcgccctggaacctcac
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M36693 158 tccaggcagaagcacagcctccccgacctgccctacgactacggcgccctggaacctcac
MCF-12A 121 atcaacgcgcagatcatgcagctgcaccacagcaagcaccacgcggcctacgtgaacaac
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M36693 218 atcaacgcgcagatcatgcagctgcaccacagcaagcaccacgcggcctacgtgaacaac
MCF-12A 181 ctgaacgtcaccgaggagaagtaccaggaggcgttggccaagggagatgttacagcccag
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M36693 278 ctgaacgtcaccgaggagaagtaccaggaggcgttggccaagggagatgttacagcccag
MCF-12A 241 atagctcttcagcctgcactgaagttcaatggtggtggtcatatcaatcatagcattttc
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M36693 338 acagctcttcagcctgcactgaagttcaatggtggtggtcatatcaatcatagcattttc
MCF-12A 301 tggacaaacctcagccctaacggtggtggagaacccaaaggggagttgctggaagccatc
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M36693 398 tggacaaacctcagccctaacggtggtggagaacccaaaggggagttgctggaagccatc
MCF-12A 361 aaacgtgactttggttcctttgacaagtttaaggagaagctgacggctgcatctgttggt
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M36693 458 aaacgtgactttggttcctttgacaagtttaaggagaagctgacggctgcatctgttggt
MCF-12A 421 gtccaaggctcaggttggggttggcttggtttcaataaggaacggggacacttacaaatt
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M36693 518 gtccaaggctcaggttggggttggcttggtttcaataaggaacggggacacttacaaatt
MCF-12A 481 gctgcttgtccaaatcaggatccactgcaaggaacaacaggccttattccactgctgggg
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M36693 578 gctgcttgtccaaatcaggatccactgcaaggaacaacaggccttattccactgctgggg
MCF-12A 541 attgatgtgtgggagcacgcttactaccttcagtataaaaatgtcaggcctgattatcta
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M36693 638 attgatgtgtgggagcacgcttactaccttcagtataaaaatgtcaggcctgattatcta
MCF-12A 601 aaagctatttggaatgtaatcaactgggagaatgtaact 639
|||||||||||||||||||||||||||||||||||||||
M36693 698 aaagctatttggaatgtaatcaactgggagaatgtaact 736
Figure 3. Alignment of nucleotide sequence of MCF-12A Mn-SOD gene with that of human GenBank (M36693) sequence.200 Sutapa Mukhopadhyay et al 2004:4 (2004)
Table 3. Comparison of nucleotide sequence of RT-PCR products of Mn-SOD gene between diﬀerent human breast cell lines.
Cell line Number of bases sequenced Aligned with M36693 (Mn-SOD) Change against M36693
MCF-12A 652 98–736 g130c, c139t, c339t
MCF-12F 637 136–732 c141t, c339t, t625c
MCF-7 631 106–736 c339t
11-9-14 640 107–746 c339t
BT-549 627 107–733 c141t
Table 4. Comparison of amino acid (AA) sequence of Mn-SOD gene between diﬀerent human breast cell lines.
Cell line Number of AA Sequenced Aligned with M36693 (Mn-SOD) Mutation against M36693
MCF-12A 217 2–214 Q12H, A16V, T82I
MCF-12F 212 15–213 A16V, T82I
MCF-7 210 5–214 T82I
BT-549 209 5–213 A16V
11-9-14 213 5–217 T82I
MCF-12A 1 LSRAVCGTSRQLAPVLGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNN 60
LSRAVCGTSRQLAP LGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNN
M36693 2 LSRAVCGTSRQLAPALGYLGSRQKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNN 61
MCF-12A 61 LNVTEEKYQEALAKGDVTAQIALQPALKFNGGGHINHSIFWTNLSPNGGGEPKGELLEAI 120
LNVTEEKYQEALAKGDVTAQ ALQPALKFNGGGHINHSIFWTNLSPNGGGEPKGELLEAI
M36693 62 LNVTEEKYQEALAKGDVTAQTALQPALKFNGGGHINHSIFWTNLSPNGGGEPKGELLEAI 121
MCF-12A 121 KRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLG 180
KRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLG
M36693 122 KRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLG 181
MCF-12A 181 IDVWEHAYYLQYKNVRPDYLKAIWNVINWENVT 213
IDVWEHAYYLQYKNVRPDYLKAIWNVINWENVT
M36693 182 IDVWEHAYYLQYKNVRPDYLKAIWNVINWENVT 214
Figure 4. Alignment of peptide sequence of MCF-12A Mn-SOD gene with that of human GenBank (M36693) sequence.
It should further be noted that this is the ﬁrst study on the
nucleotide and amino acid sequence of Mn-SOD gene in
breast epithelial cell lines. This information will be useful
in future design of experiments involving Mn-SOD gene
inbreastepithelialcelllines.Nowinourlaboratory,weare
trying to sequence the whole Mn-SOD cDNA as well as
the expression of Mn-SOD mRNA by northern blot anal-
ysis.
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